Advisory Research Inc Acadia Pharmaceuticals Inc Transaction History

Advisory Research Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$36.42 - $57.0 $744,388 - $1.17 Million	-20,439 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $196 - $263	5 Added 0.02%	20,439 $991,000
Q1 2020 May 12, 2020	BUY	$31.65 - $46.87 $15,381 - $22,778	486 Added 2.44%	20,434 $863,000
Q4 2019 Feb 11, 2020	BUY	$36.21 - $51.4 $722,317 - $1.03 Million	19,948 New	19,948 $853,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.